The Response of Osmotic Demyelination Syndrome to Plasmapheresis in a Patient Presenting with Catatonia after Correction of Hyponatraemia in Hyperemesis Gravidarum.

Autor: Rangsrisaeneepitak V; Division of Endocrinology and Metabolism, Department of Medicine, Burapha University, Chonburi, Thailand., Tekarnjnavanit A; Department of Medicine, Burapha University, Chonburi, Thailand., Kanjanapipatkul P; Division of Neurology, Department of Medicine, Burapha University, Chonburi, Thailand., Koowattanatianchai S; Division of Cardiology, Department of Medicine, Burapha University, Chonburi, Thailand.
Jazyk: angličtina
Zdroj: European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2024 Mar 11; Vol. 11 (4), pp. 004373. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
DOI: 10.12890/2024_004373
Abstrakt: Osmotic demyelination syndrome (ODS) is a disorder characterised by the widespread development of demyelination in both pontine and extrapontine regions. It has been recognised as a complication arising from the rapid correction of hyponatraemia. This study presents the case of a 20-year-old Thai female patient at 10 weeks gestation, exhibiting an initial presentation of catatonia - an uncommon manifestation of ODS. The patient developed symptoms following the rapid correction of hyponatraemia in the context of hyperemesis gravidarum. Magnetic resonance imaging (MRI) of the brain revealed a trident or bat-wing-shaped pattern in T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences at the central pons. The patient underwent five cycles of plasmapheresis and received rehabilitation, leading to clinical improvement.
Learning Points: Osmotic demyelination syndrome (ODS) is a rare but potentially devastating neurological complication, such as catatonia, resulting from the correction of hyponatraemia.Pregnancies complicated by hyperemesis gravidarum tend to exhibit hyponatraemia and hypokalaemia, which serve as contributing risk factors for ODS.Plasmapheresis is considered as an option in the treatment of ODS for the removal of inflammatory substances.
Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interests.
(© EFIM 2024.)
Databáze: MEDLINE